Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
Pancreas Cancer
Colon Cancer
Lynch Syndrome
Germline BRCA1 Gene Mutation
Germline BRCA2 Gene Mutation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 170 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vege…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age \> 18 years,
2. Individuals at increased risk of different cancers as defined within the Interception program,
3. With a baseline WCRF score ≤ 5 at entry in the Interception program,
4. Agreeing to participate and who have given their written agreement for the study,
5. A…
Contacts